Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tarsus Pharmaceuticals, Inc. - Common Stock
(NQ:
TARS
)
68.31
-2.68 (-3.78%)
Delayed Quote
Updated: 2:07 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tarsus Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Big Stocks Moving Higher On Friday: Synaptics Reports Q1 Beat; Joins Lyft, Hologic, Blink Charging
↗
November 10, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Friday. Shares of Synaptics Incorporated (NASDAQ: SYNA) rose sharply on Friday after the company reported better-than-expected...
Via
Benzinga
Topics
Stocks
Tarsus Pharmaceuticals Inc. (NASDAQ: TARS) Making Surprising Moves in Friday Session
November 10, 2023
Via
Investor Brand Network
Recap: Tarsus Pharmaceuticals Q3 Earnings
↗
November 09, 2023
Via
Benzinga
Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements
November 09, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Earnings Preview: Tarsus Pharmaceuticals
↗
November 08, 2023
Via
Benzinga
Expert Ratings for Tarsus Pharmaceuticals
↗
September 11, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Tarsus Pharmaceuticals
↗
August 14, 2023
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Tarsus Pharmaceuticals: Here's What You Need To Know
↗
July 26, 2023
Via
Benzinga
Earnings Scheduled For November 9, 2023
↗
November 09, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Via
Benzinga
Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
November 01, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Ring Nasdaq Stock Market Closing Bell in Celebration of the Launch of XDEMVY™, the First and Only FDA Approved Treatment for Demodex Blepharitis
September 06, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Present at Upcoming Investor Conferences
August 30, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis
August 24, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements
August 10, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Announces Pricing of $100.0 Million Underwritten Public Offering of Common Stock
August 01, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
August 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 31, 2023
Via
Benzinga
Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of Shares of its Common Stock
July 31, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Pharma Shares Under Pressure: Analyst Says Concerns Over Adverse Event Profile Overblown
↗
July 25, 2023
The FDA approved Tarsus Pharmaceuticals Inc's (NASDAQ: TARS) Xdemvy (lotilaner ophthalmic solution) 0.25% for
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
July 25, 2023
Via
Benzinga
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
July 25, 2023
Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.
Via
Benzinga
FDA Approves XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis
July 25, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Why Shares of Tarsus Pharmaceuticals Are Up Thursday
↗
July 20, 2023
The company's lead therapy is getting close to the finish line of FDA approval.
Via
The Motley Fool
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
July 20, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements.
Via
Benzinga
Tarsus Pharmaceuticals Inc. (NASDAQ: TARS) Climbs to New 52-Week High
July 20, 2023
Via
Investor Brand Network
Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday
↗
July 20, 2023
U.S. stocks traded mixed, with the Dow Jones gaining over 200 points on Thursday. Here are some big stocks recording gains in today’s session. Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) shares rose...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
↗
July 18, 2023
Via
Benzinga
Tarsus to Host Virtual Investor Webcast Highlighting the Commercialization Strategy, Plans and Progress for TP-03, Its Potential Treatment for Demodex Blepharitis
June 12, 2023
Webcast scheduled for Thursday, June 15 at 8:30am PT
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Present at the Jefferies Global Healthcare Conference
June 05, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023
↗
May 18, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
